Toggle navigation
Toggle navigation
About Inflarx
Leadership Team
Board
R&D
Pipeline
Products & Technology
Technology
Vilobelimab
INF904
IFX002
Clinical Development
Pyoderma Gangraenosum
COVID-19
Clinical Trials
Publications & Posters
Investors
Press Releases
Events & Presentations
Financial Information
Share Information
Analyst Coverage
Corporate Governance
Annual/Extraordinary General Meetings
E-mail alerts
Career
Open Positions
The InflaRx Commitment
Guggenheim Securities 5th Annual Inflammation & Immunology (I&I) Conference
Home
Investors
Events & Presentations
Guggenheim Securities 5th Annual Inflammation & Immunology (I&I) Conference
read more...
<< back to list
